These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24194259)

  • 1. Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk.
    Ochs-Balcom HM; Vaughn CB; Nie J; Chen Z; Thompson CL; Parekh N; Tracy R; Li L
    Cancer Causes Control; 2014 Feb; 25(2):161-70. PubMed ID: 24194259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans.
    Nock NL; Plummer SJ; Thompson CL; Casey G; Li L
    Carcinogenesis; 2011 May; 32(5):748-56. PubMed ID: 21317302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is an initiator of colon adenomas but not a promoter of colorectal cancer in the Black Women's Health Study.
    Dash C; Yu J; Nomura S; Lu J; Rosenberg L; Palmer JR; Adams-Campbell LL
    Cancer Causes Control; 2020 Apr; 31(4):291-302. PubMed ID: 32124186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.
    D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population.
    Le Marchand L; Wang H; Rinaldi S; Kaaks R; Vogt TM; Yokochi L; Decker R
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1471-7. PubMed ID: 20501760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
    Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
    Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
    Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
    Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants, prediagnostic circulating levels of insulin-like growth factors, insulin, and glucose and the risk of colorectal cancer: the Multiethnic Cohort study.
    Ollberding NJ; Cheng I; Wilkens LR; Henderson BE; Pollak MN; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):810-20. PubMed ID: 22354904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, apoptosis, and colorectal adenoma risk.
    Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.
    Bonilla C; Lewis SJ; Rowlands MA; Gaunt TR; Davey Smith G; Gunnell D; Palmer T; Donovan JL; Hamdy FC; Neal DE; Eeles R; Easton D; Kote-Jarai Z; Al Olama AA; Benlloch S; Muir K; Giles GG; Wiklund F; Grönberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Pashayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park J; Kaneva R; Batra J; Teixeira MR; Pandha H; ; Lathrop M; Martin RM; Holly JM
    Int J Cancer; 2016 Oct; 139(7):1520-33. PubMed ID: 27225428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study.
    Dash C; Palmer JR; Boggs DA; Rosenberg L; Adams-Campbell LL
    Am J Epidemiol; 2014 Jan; 179(1):112-9. PubMed ID: 24091887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.
    Platz EA; Pollak MN; Rimm EB; Majeed N; Tao Y; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1107-10. PubMed ID: 10613344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia.
    LeRoy EC; Moore JH; Hu C; Martínez ME; Lance P; Duggan D; Thompson PA
    Hum Genet; 2011 May; 129(5):503-12. PubMed ID: 21221997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating insulin-like growth factor II and colorectal adenomas.
    Renehan AG; Painter JE; O'Halloran D; Atkin WS; Potten CS; O'Dwyer ST; Shalet SM
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3402-8. PubMed ID: 10999841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
    Jung SY; Barrington WE; Lane DS; Chen C; Chlebowski R; Corbie-Smith G; Hou L; Zhang ZF; Paek MS; Crandall CJ
    Menopause; 2017 Mar; 24(3):288-298. PubMed ID: 27749737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial differences in obesity measures and risk of colorectal adenomas in a large screening population.
    Murphy CC; Martin CF; Sandler RS
    Nutr Cancer; 2015; 67(1):98-104. PubMed ID: 25425186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
    Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy.
    Lebwohl B; Capiak K; Neugut AI; Kastrinos F
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1467-73. PubMed ID: 22540887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
    Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
    Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.